[Federal Register: October 18, 1999 (Volume 64, Number 200)]
[Notices]               
[Page 56227-56228]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18oc99-83]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated March 3, 1999, and published in the Federal 
Register on April 1, 1999, (64 FR 15810), Roxane Laboratories, Inc., 
1809 Wilson Road, P.O. Box 16532, Columbus, Ohio 43216-6532, made 
application by renewal to the Drug Enforcement Administration to be 
registered as an

[[Page 56228]]

importer of cocaine (9041), a basic class of controlled substance 
listed in Schedule II.
    The firm plans to import cocaine to manufacture topical solutions 
for distribution to customers.
    A registered bulk manufacturer of cocaine filed written comments 
and an objection in response to the Notice of Application. The objector 
argues that it would not be in the public interest to register Roxane 
because it would violate United States policy against the use of seized 
material and that competition is adequate. Both of these issues have 
already been considered and addressed in Roxane's Notice of 
Registration published in the Federal Register on October 19, 1998 (63 
FR 5589).
    DEA has considered the factors in Title 21, Untied States Code, 
Section 823(a) and 952(a) and determined that the registration of 
Roxane Laboratories, Inc. to import cocaine is consistent with the 
public interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Roxane Laboratories, Inc. on a regular basis 
to ensure that the company's continued registration is consistent with 
the public interest. These investigations have included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to Section 1008(a) of the Controlled Substances 
Import and Export Act and in accordance with Title 21, Code of Federal 
Regulations, Section 1301.34, the above firm is granted registration as 
an importer of the basic class of controlled substance listed above.

    Dated: October 8, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
[FR Doc. 99-27096 Filed 10-15-99; 8:45 am]
BILLING CODE 4410-09-M